CD95 System Counter Attack and Prognostic Impact

Publisher： Karger

E-ISSN： 2296-5262|29|8-9|358-359

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.8-9, 2006-09, pp. : 358-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prognostic impact of CD109 expression in myxofibrosarcoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 8, 2015-06 ,pp. : 975-979

John Wiley & Sons Inc

Access to resources Recommend Favorite

A CD40–CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95

By Assohou-Luty Constance   Gerspach Jeanette   Siegmund Daniela   Müller Nicole   Huard Bertrand   Tiegs Gisa   Pfizenmaier Klaus   Wajant Harald  

Journal of Molecular Medicine, Vol. 84, Iss. 9, 2006-09 ,pp. : 785-797

Springer Publishing Company

Access to resources Recommend Favorite

Endoglin (CD 105) as a potential prognostic factor in neuroblastoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 770-775

John Wiley & Sons Inc

Access to resources Recommend Favorite

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 4, 2015-08 ,pp. : 558-566

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival

By  

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 111-117

Karger

Access to resources Recommend Favorite